CIK 0000313143 · Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- operating
- EIN
- 042882273
- Phone
- 7818487100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $101,148
- in 1 filing
Net −$101,148. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-07 | Scanlan Jacqueline SVP, Global Human Resources | Sale | −195 | $55.09 | $11K | 4,216 |
| 2021-06-07 | Basil Michelle L EVP and General Counsel | Sale | −442 | $55.09 | $24K | 38,605 |
| 2021-06-07 | Burke William P. Mr. EVP, Chief Financial Officer | Sale | −411 | $55.09 | $23K | 34,774 |
| 2021-06-07 | Simon, Christopher President & CEO | Sale | −2,715 | $55.09 | $150K | 193,006 |
| 2021-06-01 | Goldstein Dan VP, Corporate Controller | Grant or award | +1,753 | 4,174 | ||
| 2021-05-26 | KROLL MARK W Director | Option exercise | +10,353 | $35.50 | $368K | 30,253 |
| 2021-05-26 | KROLL MARK W Director | Sale | −11,813 | $55.10 | $651K | 18,440 |
| 2021-05-26 | KROLL MARK W Director | Option exercise · Non-qualified Stock Option (Right to Buy) | −10,353 | 0 | ||
| 2021-05-19 | Scanlan Jacqueline SVP, Global Human Resources | Sale | −112 | $55.19 | $6K | 4,411 |
| 2021-05-19 | Goldstein Dan VP, Corporate Controller | Sale | −42 | $55.19 | $2K | 2,421 |
| 2021-05-19 | Lingamneni Anila EVP, Chief Technology Officer | Sale | −92 | $55.19 | $5K | 14,202 |
| 2021-05-19 | Llorens Josep SVP, Global Manufacturing | Sale | −125 | $55.19 | $7K | 14,620 |
| 2021-05-19 | Basil Michelle L EVP and General Counsel | Sale | −220 | $55.19 | $12K | 39,047 |
| 2021-05-19 | Burke William P. Mr. EVP, Chief Financial Officer | Sale | −238 | $55.19 | $13K | 35,185 |
| 2021-05-19 | Simon, Christopher President & CEO | Sale | −1,024 | $55.19 | $57K | 195,721 |
| 2021-05-18 | Goldstein Dan VP, Corporate Controller | Grant or award | +994 | 2,463 | ||
| 2021-05-18 | Goldstein Dan VP, Corporate Controller | Grant or award · Non-qualified Stock Option (Right to Buy) | +2,690 | 2,690 | ||
| 2021-05-18 | Lingamneni Anila EVP, Chief Technology Officer | Grant or award | +3,535 | 7,224 | ||
| 2021-05-18 | Lingamneni Anila EVP, Chief Technology Officer | Grant or award | +7,070 | 14,294 | ||
| 2021-05-18 | Lingamneni Anila EVP, Chief Technology Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +9,564 | 9,564 |
Page 18 of 29 · 570 trades